Atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy in recurrent ovarian cancer

Some advanced epithelial ovarian cancer patients can avoid a lymphadenectomy without impacting survival outcomes

Immunotherapy promise for gynaecologic extra-renal clear cell carcinomas

Monitoring ovarian function in oncology studies

Novel therapies and combinations in ovarian cancer

Synthetic biology and precision medicine in blood and gynaecological cancers

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer

Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer

Atezolizumab with platinum-based CT and niraparib show no improvement in survival for rOC